Background: The aim of inhaled corticosteroid (ICS) therapy for asthma is to attain high
therapeutic activity in the airways while keeping the risk of systemic adverse effects relatively …

Purpose Studies on long‐term utilization of non‐vitamin K antagonist oral anticoagulants
(NOACs) in non‐valvular atrial fibrillation (NVAF) are scarce. We evaluated predictors of use …

The Joint Task Force for the American Academy of Allergy, Asthma and Immunology and the
American College of Allergy, Asthma and Immunology was charged with formulating a …

Systemic medications, such as antihistaminic and antiin. ammatory agents used in the
treatment of asthma and allergy, may have adverse effects on the eye. The major adverse …

Background Inhaled corticosteroids (ICS), especially when prescribed in combination with
long-acting β 2 agonists have been shown to improve COPD outcomes. Although there is …

Asthma is one of the most common conditions seen in clinical practice and carries both a
significant disease burden in terms of patient morbidity and a high economic burden in both …

Recently, a concerted effort has been made to reverse the trend of increasing asthma
mortality and morbidity. One additional strategy might be to recognize patients at risk for …

Chronic obstructive pulmonary disease (COPD) is an increasingly important public health
problem. It remains one of the leading causes of disability in developed countries and is …

Glicocorticóides são amplamente utilizados na prática clínica para o controle da atividade
de doenças auto-imunes, inflamatórias, alérgicas e outras entidades nosológicas. Doses …

Background: Due to the aging population, there is an increase in the number of elderly
patients with asthma. Although signs and symptoms are similar to those in younger patients …